Concord Biotech Limited (CONCORDBIO.NS)

INR 1733.1

(4.79%)

Total Debt Summary of Concord Biotech Limited

  • Concord Biotech Limited's latest annual total debt in 2023 was 97.37 Million INR , down -69.13% from previous year.
  • Concord Biotech Limited's latest quarterly total debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • Concord Biotech Limited reported annual total debt of 315.47 Million INR in 2022, down -49.52% from previous year.
  • Concord Biotech Limited reported annual total debt of 624.93 Million INR in 2021, down -30.01% from previous year.
  • Concord Biotech Limited reported quarterly total debt of 97.37 Million INR for 2023 Q4, down 0.0% from previous quarter.
  • Concord Biotech Limited reported quarterly total debt of 97.37 Million INR for 2023 FY, down -69.13% from previous quarter.

Annual Total Debt Chart of Concord Biotech Limited (2023 - 2019)

Historical Annual Total Debt of Concord Biotech Limited (2023 - 2019)

Year Total Debt Total Debt Growth
2023 97.37 Million INR -69.13%
2022 315.47 Million INR -49.52%
2021 624.93 Million INR -30.01%
2020 892.83 Million INR 75.19%
2019 509.63 Million INR 0.0%

Peer Total Debt Comparison of Concord Biotech Limited

Name Total Debt Total Debt Difference
Biocon Limited 162.76 Billion INR 99.94%
Blue Jet Healthcare Limited 16.12 Million INR -503.695%
Dishman Carbogen Amcis Limited 23.12 Billion INR 99.579%
Jubilant Ingrevia Limited 7.4 Billion INR 98.685%
Lyka Labs Limited 586.5 Million INR 83.397%
Panacea Biotec Limited 209.9 Million INR 53.608%
Piramal Pharma Limited 47.1 Billion INR 99.793%
SMS Lifesciences India Limited 1 Billion INR 90.332%
Supriya Lifescience Limited 54.88 Million INR -77.434%
Syngene International Limited 5.55 Billion INR 98.246%
TAKE Solutions Limited 370.85 Million INR 73.742%
Zota Health Care Limited 952.84 Million INR 89.781%